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6  Intrauterine corticosteroids for lung maturation: 
Observations of HPA axis function and cardiac 
autonomic balance in the neonate
Leonhard Schäffer, Tilo Burkhardt, Maren Tomaske, Manfred Rauh, 
and Ernst Beinder
The putative long-term effects of antenatal glucocorticoid treatment for accelerating lung 
maturation in pregnancies at risk for preterm birth is still a matter of debate. Different ani-
mal models have shown that antenatal glucocorticoid exposure has a persistent impact on 
the hypothalamus-pituitary-adrenal (HPA) – axis regulation and that the developing cardiac 
autonomic system is sensitive toward antenatal glucocorticoids. In the human, the situation 
is less clear. Long-term observations in adolescents and young adults have rather focused on 
classic signs of disease manifestation such as blood pressure. Risk-factors for cardiovascular 
and metabolic disease, however, may transform into apparent clinical manifestation at a more 
advanced age when stability of these systems can be less compensated by the organism. Our 
studies analyzed whether a single course of antenatal betamethasone treatment has a direct 
and continuous effect on the developing HPA axis and the cardiac autonomic system. To this 
end, resting- and stress-induced salivary levels for cortisol, cortisone, and α-amylase as well 
as heart rate variability parameters as early signs of system alteration were analyzed. These 
studies were conducted in healthy newborns born late preterm or at term. Our studies show 
that a single course of antenatal betamethasone treatment induces a signifi cant suppression of 
HPA-axis reactivity in healthy infants that is present several weeks later in early postnatal life. 
In contrast, the cardiac autonomic balance appears not to be primarily affected. Antenatal 
betamethasone treatment may therefore alter the HPA axis in a manner that predisposes these 
individuals toward a development of diseases in later life.
6.1 Introduction
Antenatal glucocorticoid administration is an established procedure in pregnancies 
with an imminent risk for preterm delivery . Before 34 weeks of gestation, maternal 
administration of synthetic glucocorticoids, such as betamethasone or dexamethasone , 
signifi cantly reduces perinatal mortality and morbidity by maturational effects on the 
immature fetal lungs and decreases the risk for necrotizing enterocolitis and severe 
cerebral hemorrhage (Roberts and Dalziel, 2006).
Evidence from animal models, however, suggests that excess glucocorticoid exposure 
during intrauterine development may entail long-term alterations in the functionality and 
balance of homeostasis regulating systems. Indeed, major physiologic systems involved 
in the development of hypertension and the metabolic syndrome are glucocorticoid 
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sensitive targets during intrauterine development (Drake, Tang, and Nyirenda, 2007; 
Seckl, 2004). In the rat, maternal antenatal dexamethasone treatment results in elevated 
blood pressure in the offspring (Benediktsson et al., 1993; Woods and Weeks, 2005). 
Likewise, the maternal administration of dexamethasone in the sheep induces hyperten-
sion during adulthood (Dodic et al., 1998, 2002). Glucocorticoid s are likewise involved 
in programming of glucose tolerance and metabolism. Again, in the rat as well as in 
the sheep, persistent alterations in glucose and insulin levels have been found in adult 
offspring after intrauterine glucocorticoid exposure (Moss et al., 2001; Nyirenda et al., 
1998).
6.2 Vulnerability of the hypothalamic-pituitary-adrenal (HPA) axis
The hypothalamic-pituitary-adrenal (HPA) axis represents the organism’s central organ 
of stress regulation and is involved in preservation of cardiovascular and metabolic 
stability, and elevated cortisol levels have been linked to arteriosclerosis and diabetes 
(Sapolsky, Romero, and Munck, 2000). The HPA axis and its key limbic regulator, the 
hippocampus, are especially sensitive to glucocorticoids because this system is tightly 
regulated through a feedback mechanism involving glucocorticoid (GR) and mineralo-
corticoid receptors (MR) at the level of the hippocampus, hypothalamus, and pituitary 
gland to inhibit HPA activity ( Jacobson and Sapolsky, 1991). The HPA axis has been 
shown to be vulnerable to excess glucocorticoid exposure during its maturational stage 
(Kapoor, Petropoulos, and Matthews, 2008; Owen, Andrews, and Matthews, 2005). 
As such, overexposure to glucocorticoids results in attenuated hippocampal GR and 
MR expression. The resulting permanently increased cortisol levels and hypertension in 
the adult rats suggest an impaired negative feedback sensitivity of the HPA axis (Levitt 
et al., 1996). Further alterations at different levels of the HPA axis are likewise targets 
of glucocorticoid receptor alterations (Dean et al., 2001). Thus, glucocorticoid induced 
permanent alterations of these receptors may induce a resetting of the balance and 
reactivity of the HPA axis in later life.
6.3 Vulnerability of the sympathetic nervous system
The sympathetic nervous system (SNS) development has been shown to be sensitive 
toward antenatal glucocorticoids as well. In fact, the SNS is closely interconnected with 
the HPA axis as glucocorticoids provide direct signals for noradrenergic system matura-
tion in the brainstem and thus on central noradrenergic activity (Slotkin et al., 1992). 
Furthermore, cardiac noradrenergic innervation is directly affected by glucocorticoids 
(Bian, Seidler, and Slotkin, 1993). Adrenergic cardiovascular drive and noradrenergic 
infl uences play a key role in the development or progression of hypertension and the 
metabolic syndrome in the adult (Grassi et al., 2009), making this system another key 
candidate for glucocorticoid induced long-term alterations in system balance. This no-
tion is supported by experiments showing a sustained elevation of blood pressure and 
altered baroreceptor heart rate response in fetal sheep and the baboon and increased 
central and peripheral vascular resistance after glucocorticoid administration (Derks 
et al., 1997; Fletcher et al., 2002; Koenen et al., 2002; Schwab et al., 2000).
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6.4 Findings in humans
Findings of putative alterations of HPA-axis activity and SNS balance in the human 
after intrauterine glucocorticoid exposure are less clear. Premature neonates failed to 
increase cortisol levels in response to a stressor after intrauterine exposure to gluco-
corticoids for lung maturation (Davis et al., 2004, 2006). In the neonate as well as in a 
cohort of preterm born children at the age of 14 years, blood pressure was signifi cantly 
increased after prenatal glucocorticoid treatment (Doyle et al., 2000; Kari et al., 1994). 
In contrast, a large prospective follow-up study did not fi nd signifi cant alterations in 
blood pressure and resting cortisol levels in 30-year-old adults after a single course 
of antenatal betamethasone treatment for lung maturation. Physiological functional-
ity when challenging these systems was not available. Nevertheless, during a glucose 
challenge, clear indicators for the presence of insulin resistance were present in these 
individuals (Dalziel et al., 2005). In fact, studies have mainly focused on classical signs 
of disease manifestation; however, these signs may not become apparent until a later 
age when compensatory mechanisms fail after a certain threshold is reached.
If indeed the HPA axis and the SNS experience permanent alterations after intrauter-
ine glucocorticoid exposure, these alterations should be detectible after birth. Consider-
ing the fact that these alterations may be mild and clinically not apparent during early 
life due to a high compensatory reserve being only “exhausted” over many years, we 
aimed to not only analyze HPA and SNS balance under resting conditions but also to 
challenge these systems.
A further rationale to analyze these systems in neonates was that in a normal postna-
tal period, temporarily challenged systems normalize in response to a normal postnatal 
environment, while permanently altered systems may become apparent, but postnatal 
compensatory system reactions may not have had the time to develop.
6.5  HPA axis functionality in neonates after intrauterine 
betamethasone treatment
To analyze the functionality of the HPA axis, we applied a simple noninvasive method 
by measuring cortisol and cortisone levels in salivary samples. Salivary cortisol refl ects 
the unbound, active fraction of cortisol and is highly correlated with plasma cortisol 
levels (Calixto et al., 2002; Gunnar, 1989), making this method especially valuable 
for infants where blood sampling is less desired by parents. Likewise, to analyze for 
functionality under challenge, we made use of the routinely conducted heel-prick test 
72–96 h after delivery, which has been shown to be an adequate stimulus for HPA-axis 
activation (Gunnar, 1992). Resting cortisol levels and cortisol levels after this challenge 
were measured. While resting levels of cortisol were comparable between the infants 
with antenatal betamethasone treatment and controls, we found that the neonatal 
HPA axis was signifi cantly suppressed in infants with betamethasone treatment after 
the stimulus as these infants failed to adequately increase cortisol release (Schäffer 
et al., 2009; ?Fig. 6.1). Because these infants were born near or at term and the mean 
interval between glucocorticoid treatment and delivery was more than 8 weeks, it is 
rather unlikely that these effects may only be a transient short-term effect consider-
ing that short-term effects of antenatal glucocorticoid exposure have been described to 
last for about 1 week after administration (Ballard et al., 1980; Parker et al., 1996). The 
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possibility that the decreased cortisol response in the study group would be the result 
of an increased conversion of cortisol to cortisone by an altered activity of the 11-beta 
hydroxysteroid dehydrogenase could also be excluded because cortisol and cortisone 
levels were strongly correlated in the study group, thus excluding this possibility. There-
fore, it appears that a single course of antenatal betamethasone treatment for imminent 
preterm delivery has a suppressive effect on HPA-axis reactivity that persists at least 
for more than a mean of 8 weeks when these pregnancies continue and infants are 
delivered near or at term.
6.6  The cardiac autonomic system after intrauterine 
betamethasone treatment
A sensitive parameter to analyze early alterations in the cardiac sympathetic – 
 parasympathetic balance is heart rate variability (HRV), which is a well-established 
noninvasive measure of cardiac autonomic control that has been shown to be related to 
hypertension (Guzzetti et al., 1991; Langewitz, Ruddel, and Schachinger, 1994) and to 
predict future adverse cardiovascular events in adults (Algra et al., 1993). Analyses of HRV 
have been suggested for putative prognostic use in children as well (Stewart, 2000). Analy-
sis from 24 h Holter electrocardiogram (ECG) tracings calculating various parameters for 
short- and long-term analyses during active and resting states did not reveal any signifi cant 
difference between betamethasone exposed infants and controls (Schäffer et al., 2010).
To further support our conclusion, we supplemented our electrophysiological studies 
by measuring salivary α-amylase levels during resting conditions and after a stressful 
stimulus (heel-prick test). Salivary α-amylase is secreted by acinar cells in the salivary 
glands that are richly innervated by both sympathetic and parasympathetic nerve fi bers, 
infl uencing the release of α-amylase by classic neurotransmitters (Turner and Sugiya, 
2002). Studies in humans and animals have suggested that the activation of the auto-
nomic nervous system leads to a high activity of salivary α-amylase (Asking and Gjor-
strup, 1987; Chatterton et al., 1996; Schneyer and Hall, 1991; Steerenberg et al., 1997). 
Furthermore, α-amylase levels have been found to be associated with cardiovascular 
Fig. 6.1: Median cortisol levels during resting- (baseline) and post-stress induction (5 min. 
post, 20 min. post) phases in betamethasone exposed neonates (- - -) and controls (----). Arrow 
indicates stress induction. *p < 0.05, n.s.: not signifi cant.
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physiology and are suggested to be a surrogate for cardiovascular autonomic system 
balance (Granger et al., 2007), thereby making this parameter a promising indicator for 
cardiac autonomic function.
Interestingly, α-amylase levels rather decreased in betamethasone -exposed neo-
nates in response to the stress event as compared to controls (Schäffer et al., 2010). 
We speculate that the slightly attenuated α-amylase response might be explained by 
the altered HPA-system sensitivity rather than by direct effects of steroid exposure 
on the sympathetic system as these systems are closely interconnected. Thus, it appears 
that the neonatal cardiac autonomic system is primarily unaffected by a single course of 
betamethasone treatment for lung maturation.
6.7 Summary
To our best knowledge, the presented studies are the fi rst to analyze stress physiology 
in healthy term or near term delivered infants after a single course of betamethasone 
administration at a much earlier time in pregnancy. These early signs for alterations in 
the balance and activity of the HPA axis and the cardiac autonomic system may further 
contribute to the understanding of origins of disease development.
According to our results, a single course of antenatal betamethasone treatment for 
imminent preterm delivery entails alterations in HPA-axis responsiveness that persist 
into postnatal life. If this alteration of the HPA-axis balance really persists during life, 
it may represent a signifi cant risk factor for the development of diseases in later life. In 
contrast, according to our results, cardiac autonomic balance appears to be preserved 
after exogenous glucocorticoid treatment at least in the neonate. However, due to the 
mutual interaction between the HPA axis and the SNS, this system may be subject to 
later alterations as the organism further matures.
Considering the benefi cial effects of antenatal glucocorticoids to signifi cantly re-
duce infant morbidity and mortality in pregnancies at risk for preterm delivery before 
34 weeks of gestation, it is clear that these measures outweigh putative long-term 
risks according to current knowledge. Nevertheless, thorough evaluation in these cases 
is mandatory to ensure a clear indication for antenatal glucocorticoids. Prophylactic 
 treatment in low-risk situations for preterm delivery should be avoided.
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